Panbela Therapeutics Inc (STU:X70)
€ 119.4 0 (0%) Market Cap: 1.54 Mil Enterprise Value: 7.54 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 27/100

Q1 2022 Panbela Therapeutics Inc Earnings Call Transcript

May 12, 2022 / 08:30PM GMT
Operator

Good afternoon, ladies and gentlemen. Thank you for standing by. Welcome to the Panbela Therapeutics' first-quarter 2022 earnings call. At this time, all participants are in a listen-only mode.

After management's prepared remarks, there will be a question-and-answer session. I would now like to turn the call over to the host, James Carbonara, Investor Relations at Hayden. Please go ahead.

James Carbonara
Hayden - IR

Thank you. And once again, welcome to Panbela's first-quarter 2022 earnings call. With me on the call are Jennifer Simpson, Chief Executive Officer; and Sue Horvath, Chief Financial Officer.

Before I turn the call over to Dr. Simpson, please note that statements made on this call that are not historical facts may be forward-looking statements. Significant risks and uncertainties that could cause actual results to differ from those expressed or implied in the forward-looking statements are detailed in the company's annual report on Form 10-K and supplemented by subsequently filed quarterly reports on Form 10-Q as well as in other

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot